1. travel
2. tourist destinations
3. japan

Updated on February 17, 2015
Thursday, March 26, 2015
18:50-19:30, Thursday, March 26, 2015
Plenary Hall (3F)
Plenary Lecture 1
Moderator: Chun-Ming Lee (Taiwan)
PL 1
From Care Bundles to Multimodal Interventions: Infection Control at His Best
Didier Pittet (Switzerland)
Friday, March 27, 2015
8:30-9:10, Friday, March 27, 2015
Plenary Hall (3F)
Plenary Lecture 2
Moderator: Shan-Chwen Chang (Taiwan)
PL 2
Environmental Disinfection of Hospitals
Moi Lin Ling (Singapore)
9:20-10:00, Friday, March 27, 2015
Plenary Hall (3F)
Keynote Speech 1
Moderator: TBD
KS 1
From SARS, MERS and Ebola
Kwok Yung Yuen (Hong Kong, SAR)
9:20-10:00, Friday, March 27, 2015
Room 102 (1F)
Keynote Speech 2
Moderators: Hsieh-Shong Leu (Taiwan)
KS 2
The Changing Face of Acinetobacter baumannii Epidemiology and its Control Issue
Anucha Apisarnthanarak (Thailand)
9:20-10:00, Friday, March 27, 2015
Room 201 ABC (2F)
Keynote Speech 3
Moderator: Wing Hong Seto (Hong Kong, SAR)
KS 3
Prevention and Control of MDR-Acinetobacter baumannii: Evidence and Challenge
Bijie Hu (China)
9:20-10:00, Friday, March 27, 2015
Room 201 DEF (2F)
Keynote Speech 4
Moderator: Didier Pittet (Switzerland)
KS 4
Emergence of Azole Resistant Aspergillus in Hospitals and Role of the Environment. Only a
European Problem or is Asia Next?
Jacques F. Meis (The Netherlands)
1
Updated on February 17, 2015
10:30-12:00, Friday, March 27, 2015
Plenary Hall (3F)
Symposium 1
Implementation of the Comprehensive Program to Eliminate Healthcare-associated Infections and Antimicrobial
Resistance
Moderators: Hsu-Sung Kuo (Taiwan); Andreas Voss (The Netherlands)
SP 1-1
National Response and Action: Perspective and Challenges of Antimicrobial Stewardship in
Taiwan
Feng-Yee Chang (Taiwan)
SP 1-2
Action Plan to Prevent Healthcare-associated Infections and Antimicrobial Resistance in
Singapore
David Chien Boon Lye (Singapore)
SP 1-3
Action Plan to Prevent Healthcare-Associated Infections and Antimicrobial Resistance in Hong
Kong
Tin-Yau Andrew Wong (Hong Kong, SAR)
10:30-12:00, Friday, March 27, 2015
Room 102 (1F)
Symposium 2
The Role of Environmental Cleaning for Curbing Hospital Pathogens
Moderators: Anucha Apisarnthanarak (Thailand); Min-Chi Lu (Taiwan)
SP 2-1
The Environment and Healthcare-acquired Infections
Stephan Harbarth (Switzerland)
SP 2-2
Implementation of Environmental Cleaning Program
Moi Lin Ling (Singapore)
SP 2-3
Novel Technology for Environmental Cleaning
Trish Perl (United States)
SP 2-4
Best Practices for Sterilization and HLD of Reusable Medical Devices
Cheri Ackert-Burr (United States)
10:30-12:00, Friday, March 27, 2015
Room 201 ABC (2F)
Symposium 3
Challenges in Infection Prevention and Control: More Clean, More Safe
Moderators: Kyungwon Lee (Korea); Jien-Wei Liu (Taiwan)
SP 3-1
National Hand Hygiene Campaign in Korea - Progress and Challenges
Hong Bin Kim (Korea)
SP 3-2
Hand Hygiene (HH) Promotion and Culture Innovation
Wing Hong Seto (Hong Kong, SAR)
SP 3-3
Hand Hygiene - From Policy to Practice
Yee-Chun Chen (Taiwan)
SP 3-4
HAI: Actual Risk from the Environment?
Hung Suet Lam (Hong Kong, SAR)
2
Updated on February 17, 2015
10:30-12:00, Friday, March 27, 2015
Room 201 DEF (2F)
Symposium 4
Infection Control in Pediatrics
Moderators: Chia Yin Chong (Singapore); Yhu-Chering Huang (Taiwan)
SP 4-1
Respiratory Syncytial Virus (RSV) - A Key Player for Severe Infections in Special Populations
David Greenberg (Israel)
SP 4-2
Prevention of Nosocomial Bacterial Infections in Pediatrics and Neonatology
Chia Yin Chong (Singapore)
SP 4-3
Prevention and Infection Control for Noroviral Infection
Cheng-Hsun Chiu (Taiwan)
10:30-12:00, Friday, March 27, 2015
Room 103 (1F)
Symposium 5
Current Management of Fungal and Viral Infections
Moderators: Owen Tsang (Hong Kong, SAR); Wing-Wai Wong (Taiwan)
SP 5-1
Infections Caused by Rare Fungi
Jacques F. Meis (The Netherlands)
SP 5-2
Current Management of Chronic Hepatitis C
Owen Tsang (Hong Kong, SAR)
SP 5-3
Current Management of HIV Infection
Chien-Ching Hung (Taiwan)
3
Updated on February 17, 2015
10:30-12:00, Friday, March 27, 2015
Room 105 (1F)
Oral Session 1
Moderator: Hsin-Chih Lai (Taiwan); TBD
OS 1-1
Pyrosequencing of Mycobacterium Tuberculosis Drug-resistance Gene Mutations of Detection
Linhan Feng (China)
OS 1-2
Evaluation of Different Cutoff Points for Quantiferon®-TB Gold In-tube Among Tuberculosis
Contacts
Pei Chun Chan (Taiwan)
OS 1-3
Risk of Active Tuberculosis Among HIV-infected TB Contacts, Taiwan, 2008-2012
Pin-Hui Lee (Taiwan)
OS 1-4
Cesarean Section Surgical Site Infection Caused by Mycobacterium massiliense
Ting-Shu Wu (Taiwan)
OS 1-5
First Report of One Neglected Hypervirulent (hypermucoviscous) and Pan-susceptible
Klebsiella pneumoniae ST86 Strain Causing Fatal Infections in China
Yibo Zhang (China)
OS 1-6
Research in the Virulence of Candida
Shuxian Chen (China)
OS 1-7
Aspergillus Spp. in ICUs: Spectrum of Infections with Antifungal Susceptibility Patterns of
Clinical and Environmental Isolates
Yubhisha Dabas (India)
OS 1-8
Toll-like Receptor Polymorphisms as Risk Factor for Clostridium difficile Associated Diarrhea
Yuan-Pin Hung (Taiwan)
OS 1-9
Matrix-assisted Laser Dersorption/ionization Time-of –flight Mass Spectrometry for the
Identification of Beta-hemolytic Streptococci
Xiangru Ye (China)
13:40-14:20, Friday, March 27, 2015
Plenary Hall (3F)
Keynote Speech 5
Moderator: Hung Suet Lam (Hong Kong, SAR)
KS 5
The Infection Control of Dental Practice in Taiwan
Hsin-Chung Cheng (Taiwan)
13:40-14:20, Friday, March 27, 2015
Room 102 (1F)
Keynote Speech 6
Moderators: Wei-Juin Su (Taiwan)
KS 6
Environmental Control of Tuberculosis
Edward A Nardell (United States)
13:40-14:20, Friday, March 27, 2015
Room 201 ABC (2F)
Keynote Speech 7
Moderators: Ming-Yuan Chou (Taiwan)
KS 7
Top Quality Improvement Initiatives in 2014-2015
Glenys Harrington (Australia)
4
Updated on February 17, 2015
13:40-14:20, Friday, March 27, 2015
Room 201 DEF (2F)
Keynote Speech 8
Moderator: Kyungwon Lee (Korea)
KS 8
The Importance of Management of Surface Environment in Controlling Healthcare-associated
Infections
David Jay Weber (United States)
15:00-16:30, Friday, March 27, 2015
Plenary Hall (3F)
Symposium 6
Infection Prevention and Control in Healthcare Settings
Moderators: Jih-Haw Chou (Taiwan); Satowa Suzuki (Japan)
SP 6-1
National Implementation of Antimicrobial Stewardship Programs
Marilyn Cruickshank (Australia)
SP 6 -2
Surveillance System of Antimicrobial Resistance and Healthcare - Associated Infections in
Japan
Satowa Suzuki (Japan)
SP 6-3
Implementation of Bundle Care to Decrease Healthcare Associated Infections in Taiwan
Wang-Huei Sheng (Taiwan)
15:00-16:30, Friday, March 27, 2015
Room 102 (1F)
Symposium 7 (Co-organized by ISC Working Group on Clostridium difficile Infections)
Clostridium difficile Infections (CDI)
Moderators: Ellie J.C. Goldstein (United States); Wen-Chien Ko (Taiwan)
SP 7-1
C difficile Infection in Western Countries: Underdiagnoses, Epidemiology & Evolving Therapies
Ellie J.C. Goldstein (United States)
SP 7-2
Hypervirulent Clostridium difficile in Asia
Thomas Riley (Australia)
SP 7-3
Infection Control of Clostridium difficile Infection
Wen-Chien Ko (Taiwan)
15:00-16:30, Friday, March 27, 2015
Room 201 ABC (2F)
Symposium 8 (Co-organized by Taiwan AIDS Society)
Global Prevention of HIV Infection in Advance HAART Era
Moderators: Vladimir Krcmery (Slovakia); Hsi-Hsun Lin (Taiwan)
SP 8-1
Treatment as Prevention: How to Make it Work?
Kiat Ruxrungtham (Thailand)
SP 8-2
Preliminary Experience of Nonoccupational Postexposure Prophylaxis (nPEP) in Taipei
Chia-Jui Yang (Taiwan)
SP 8-3
Nosocomial HIV Infections - Lessons from History
Vladimir Krcmery (Slovakia)
5
Updated on February 17, 2015
15:00-16:30, Friday, March 27, 2015
Room 201 DEF (2F)
Symposium 9 (Co-organized by ISC Working Group on Urinary Tract Infections & Asian Association of UTI and STD)
Uro-genital Infections
Moderators: Seung-Ju Lee (Korea); Yeu-Jun Lau (Taiwan)
SP 9-1
Risk Factors for STI
Ryoichi Hamasuna (Japan)
SP 9-2
Antimicrobial Resistance in Urinary Tract Infections- Asian Data from the Global Prevalence
Study of Infections in Urology-GPIU
Seung-Ju Lee (Korea)
SP 9-3
Prevention and Control of Catheter Associated Urinary Tract Infection
Paul Anantharajah Tambyah (Singapore)
15:00-16:30, Friday, March 27, 2015
Room 103 (1F)
Symposium 10
Vaccine Preventable Diseases
Moderators: David Greenberg (Israel); Li-Min Huang (Taiwan)
SP 10-1
Streptococcus pneumoniae
David Greenberg (Israel)
SP 10-2
Immunization Across the Lifespan: Adult Vaccinations
Eddy A. Bresnitz (United States)
SP 10-3
Transmission, Outcomes and Vaccine Development of Enterovirus 71
Luan-Yin Chang (Taiwan)
15:00-16:30, Friday, March 27, 2015
Room 105 (1F)
Oral Session 2
Moderator: Trish Perl (United States); Jen-Hsien Wang (Taiwan)
OS 2-1
Efficacy of a Local Hospital to Advocate CVC Bundlecare for Declining Blood Stream Infection
Chia-Yun Pan (Taiwan)
OS 2-2
Improvement on Hospital Environment Hygiene to Control the Spread of Multiple-drugs
Resistant Organisms (MDROs)
Annie Leung (Hong Kong, SAR)
OS 2-3
Implementation of Bundle Care for Prevention of Central Line Associated Bloodstream
Infection at Intensive Care Units
Yuching Chang (Taiwan)
OS 2-4
Evaluation on a Bundle of Infection Control Interventions Against an Infection Caused by Tick
Borne Pathogens: a Retrospective Comparative Study
Xiu-Bin Tao (Taiwan)
OS 2-5
Nurse Directed Interventions to Reduce the Catheter Associated Urinary Tract Infections in an
Intensive Care Unit in Southern Taiwan
Yeuh-Ju Chen (Taiwan)
OS 2-6
Evaluation of Sequential Enhanced Cleaning to Remove Multidrug-resistant Organisms on
High-touch Surfaces in Medical Intensive Care Unit
Tieer Gan (China)
6
Updated on February 17, 2015
OS 2-7
Using CVC Bundle Care Model to Improve the Effectiveness of the Implementation of
Bloodstream Infection in Cancer Ward
Ching-Ting Lien (Taiwan)
OS 2-8
Application of Bundle Intervention in Reducing Central Venous Catheter-related Bloodstream
Infections
Xiaoqin Wu (China)
OS 2-9
Decrease MDRO by Team-work Model Bundle Care
Pai Mei Chao (Taiwan)
16:30-18:00, Friday, March 27, 2015
Room 103 (1F)
Oral Session 3
Moderator: Po-Yen Chen (Taiwan); Chun-Mei Lu (Taiwan)
OS 3-1
An Effectiveness of HIV/AIDS Prevention Model in Akha Youths, Thailand
Tawatchai Apidechkul (Thailand)
OS 3-2
Effectiveness of a Reduced Dose of Efavirenz Plus 2 NRTIs as Maintenance Antiretroviral
Therapy with the Guidance of Therapeutic Drug Monitoring
Chien-Ching Hung (Taiwan)
OS 3-3
Trends and Outcome of HIV-positive Patients with Late Presentation for Combination
Antiretroviral Therapy in Taiwan: A Cohort Study
Chien-Ching Hung (Taiwan)
OS 3-4
Healthcare Utilization Associated with Influenza Like Illness: a Survey in the General
Population of Hong Kong
Lin Yang (Hong Kong, SAR)
OS 3-5
Molecular Determinants of Human Defense Against Avian Influenza Virus Infection
Shu-Ming Kuo (Taiwan)
OS 3-6
Outbreak Investigation of Pandemic Influenza a H1N1 at the Emergency Department in a
Medical Center in Southern Taiwan
Chin-Mei Ke (China)
OS 3-7
The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic
Hepatitis B Virus Infection
Jia-Feng Wu (Taiwan)
OS 3-8
Prevalence and Risk Factors of Hepatitis B Infection in Pregnant Women at the Prenatal Clinic
of the University of the Philippines- Philippine General Hospital
Aubrey Taguba (Philippines)
OS 3-9
Seroprevalence of Human Herpesvirus Type 8 Infection in Patients with Tuberculosis
Cheng-Chuan Su (Taiwan)
7
Updated on February 17, 2015
16:30-18:00, Friday, March 27, 2015
Room 105 (1F)
Oral Session 4
Moderator: Po-Liang Lu (Taiwan); Nai-Ying Ko (Taiwan)
OS 4-1
Worldwide Improper Bedpan-management: Risk for Spreading (MULTI Drug) Resistant
Organisms
Gertie Van Knippenberg-Gordebeke (Netherlands)
OS 4-2
Impact of Broad Spectrum, Pseudomonas-sparing Antimicrobial Treatment on Microbiological
Ecology of Intestinal Flora
Jen-Jia Yang (Taiwan)
OS 4-3
Carbapenemase Producing Klebsiella pneumoniae, an Emerging Problem in a Tertiary
Healthcare Setting
Cindy Shuan Ju Teh (Malaysia)
OS 4-4
Mobilization of NDM-ISCR1 Element in Escherichia coli in a Patient
Juan Li (China)
OS 4-5
SCC mec Typing of MRSA Isolates from a Tertiary Care Hospital in Mysore
Madhuri Kulkarni (India)
OS 4-6
Linezolid-resistant MRSA Strains Sequentially Isolated from an Elderly Patient with Pneumonia
During Prolonged Therapy with Linezolid
Shan Zhou (China)
OS 4-7
Correlation of Molecular Types with Antimicrobial Susceptibility Profiles among 670 mecA+
MRSA Isolates from Sterile Sites (TIST Study, 2006-2010)
Wei-Yao Wang (Taiwan)
OS 4-8
Distribution and Drug Resistance of Pathogens Cultured from 63229 Blood Specimens
Linhan Feng (China)
OS 4-9
Role of Cefepime Therapy for Carbapenem-resistant Klebsiella pneumoniae Bloodstream
Infections
Ching-Lung Lo (Taiwan)
8
Updated on February 17, 2015
Saturday, March 28, 2015
7:30-8:30, Saturday, March 28, 2015
Room 102 (1F)
Oral Session 5
Moderator: Nan-Chang Chiu (Taiwan); Hui-Chun Chung (Taiwan)
OS 5-1
Carbapenem-resistant Versus Carbapenem-susceptible Acinetobacter Baumannii Bacteremia in
a Teaching Hospital in China: Risk Factors and Outcomes
Fu Qiao (China)
OS 5-2
Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients with Carbapenem
Non-susceptible Klebsiella Pneumoniae Infection: a Multicenter Study in Taiwan
Yi-Tsung Lin (Taiwan)
OS 5-3
Epidemiology and Management Vencomycin Resistant Enterococci and Carbapenem Resistant
Enterobacteriaceae in Low Resource Hospital in Thailand
Aree Goonna (Thailand)
OS 5-4
Implementation of Bundle Care to Decrease Healthcare Associated Infections Caused by
Multidrug Resistant Bacteria at a Medical Center
Wang-Huei Sheng (Taiwan)
OS 5-5
Containment of Klebsiella pneumoniae Carbapenemase in the Acute Stroke Icu of Manila
Doctors Hospital: an Outbreak Investigation Case Study
Aisa Jensen Lee (Philippines)
OS 5-6
Emergence of Community-acquired Extended-spectrum-beta-lactamase-producing Escherichia
coli Uropathogen in Children: Prevalence of CTX-M 14 in E. Coli O25b-ST131
Yun-Wen Chen (Taiwan)
7:30-8:30, Saturday, March 28, 2015
Room 201 ABC (2F)
Oral Session 6
Moderator: Allen Cheng (Australia); Yu-Jiun Chan (Taiwan)
OS 6-1
Development of an Electronic Surveillance and Intervention System for Healthcare-associated
Infection
Yan Gao (China)
OS 6-2
Effectiveness and Cost of Implementation an Active Surveillance Screening Policy for
Carbapenem-resistant A. Baumanni and Vancomycin-resistant Enteroccci in an Infectious
Diseases Ward in Taiwan
Ching-Hsien Li (Taiwan)
OS 6-3
Bacteremia Caused by Contaminated Intravenous Drip Drug
Ling-Li Huang (Taiwan)
OS 6-4
Validation and Comparison of a Candidemia Prediction Models: A Case-control Study
Yi-Ju Tseng (Taiwan)
OS 6-5
Development and Evaluation of a Hospital-wide Healthcare-associated Surgical Site Infection
Detection Algorithm
Yi-Ju Tseng (Taiwan)
OS 6-6
5-year Longitudinal Follow-up of Serological Responses to Primary Vaccination with 1 Dose
Versus 2 Doses of 7-valent Pneumococcal Conjugate Vaccine in Hiv-infected Patients in the
9
Updated on February 17, 2015
Cart Era
Chien-Ching Hung (Taiwan)
7:30-8:30, Saturday, March 28, 2015
Room 201 DEF (2F)
Oral Session 7
Moderator: Kong Chan (Macau, SAR); TBD
OS 7-1
Impact of up Gradation of Surveillance Methodology in Health Care–acquired Infections (HAIs)
Debkishore Gupta (India)
OS 7-2
Dialysis Surveillance Analysis of Hemodialysis Outpatients in a Large Hospital
Zhang Hui (China)
OS 7-3
Bacteremia in Adult Patients with Hematopoietic Stem Cell Transplantation: A 10-year
Experience with Fluoroquinolone Prophylaxis of a Single Center in Taiwan
Ching Hsun Wang (Taiwan)
OS 7-4
The Analysis of 598 Cases of Nosocomial Infections
Shilan Xu (China)
OS 7-5
Surveillance on Catheter-associated Urinary Tract Infection in Intensive Care Units in Shanghai,
China: a Retrospective Observational Study
Chendi Zhu (China)
OS 7-6
Comparative Study of Surveillance Method of Healthcare Associated Infections Based on Point
Prevalence Survey and Hospital-wide Surveillanc
Juyuan Liu (China)
7:30-8:30, Saturday, March 28, 2015
Room 103 (1F)
Oral Session 8
Moderator: Shin-Jung Lee (Taiwan); Yu-Hui Chen (Taiwan)
OS 8-1
Influence of Wolbachia on Malaysian Aedes Albopictus
Sylvia Joanne (Malaysia)
OS 8-2
The Epidemiology of Human Q Fever and the Association Between Human Q Fever and
Animals in Taiwan, 2004 to 2012
Chung-Hsu Lai (Taiwan)
OS 8-3
Correlation Between Gut Microbiota Composition and Parasitic Infection of Pre-adolescence in
Malaysia
Chun Wie Chong (Malaysia)
OS 8-4
Development the Detection Method of Sarcocystis DNA from Stool Specimen as the Proof for
Foodborne Cases
Yuko Watanabe Murakami (Japan)
OS 8-5
System Biology Analyses of the Dynamic Host Response to Toxoplasma Gondii Infection in a
Murine Model
Ivan Yap (Malaysia)
OS 8-6
Incrimination of Anopheles balabacensis as the Vector for Simian Malaria in Kudat Division,
Sabah, Malaysia
Meng Li Wong (Malaysia)
10
Updated on February 17, 2015
7:30-8:30, Saturday, March 28, 2015
Room 105 (1F)
Oral Session 9
Moderator: Chang-Pan Liu (Taiwan); Yen-Ling Lu (Taiwan)
OS 9-1
Reducing Antibiotic Resistant Pathogens (ARPs) and Primary Bloodstream Infections in the
Intensive Care Unit (ICU) Setting in the Asia Pacific Region
Moi Lin Ling (Singapore)
OS 9-2
Different Expressions of the Toll-like Receptors (TLRs) and Related Factors in Peripheral Blood
of Preterm Infants
Jinping Zhang (China)
OS 9-3
A Chlorhexidine Gluconate (CHG) Containing Dressing for the Cost-effective Reduction of
Catheter Related Bloodstream Infection
Patrick Parks (United States)
OS 9-4
The Risk Factors for Mortality in Liver Transplant Recipients with Bloodstream Infections
Ching Ching Chang (Taiwan)
OS 9-5
Clinical and Microbial Characteristics of 679 Episodes of Bloodstream Infections
Yumeng Yao (China)
OS 9-6
What Do We Learn from Antimicrobial Photodynamic Therapy?
Tak-Wah Wong (Taiwan)
8:30-9:10, Saturday, March 28, 2015
Plenary Hall (3F)
Plenary Lecture 3
Moderators: Yin-Ching Chuang (Taiwan)
PL 3
Clean Care is Safer Care: Surgical Site Infection
Joseph Solomkin (United States)
9:20-10:00, Saturday, March 28, 2015
Plenary Hall (3F)
Keynote Speech 9
Moderator: Didier Pittet (Switzerland)
KS 9
All Time Top Infection Control Literature
Robert A. Weinstein (USA)
9:20-10:00, Saturday, March 28, 2015
Room 102 (1F)
Keynote Speech 10
Moderator: Kwen-Tay Luh (Taiwan)
KS 10
The Emerging Global Challenge of Nontuberculous Mycobacterial (NTM) Infections
David E. Griffith (United States)
9:20-10:00, Saturday, March 28, 2015
Room 201 ABC (2F)
Keynote Speech 11
Moderator: Jang-Jih Lu (Taiwan)
KS 11
The Impact of Emerging New Diagnostic Techniques on Clinical Infectious Disease
Franklin R. Cockerill (United States)
11
Updated on February 17, 2015
9:20-10:00, Saturday, March 28, 2015
Room 201 DEF (2F)
Keynote Speech 12
Moderator: William R. Jarvis (USA)
KS 12
Antimicrobial Stewardship Program in Hospitals: Taiwan Experience
Shan-Chwen Chang (Taiwan)
10:30-12:00, Saturday, March 28, 2015
Plenary Hall (3F)
Symposium 11
Ebola Virus Disease
Moderators: Dale Fisher (Australia); Kao-Pin Hwang (Taiwan)
SP 11-1
What Went Wrong in West Africa and Where are we Headed
Dale Fisher (Singapore)
SP 11-2
Ebola Bio-safety and Laboratory Testing
Yun F (Wayne) Wang (United States)
SP 11-3
Fight Against Ebola: Preparedness and Public Health Response
Yi-Chun Lo (Taiwan)
10:30-12:00, Saturday, March 28, 2015
Symposium 12
Room 102 (1F)
(Co-organized by Yoshida Pharmaceutical Company Limited)
Strategies for New Problems on Healthcare-Associated Infections
Moderators:
Hiroyoshi Kobayashi (Japan); Po-Ren Hsueh (Taiwan)
SP 12-1
Strategies for New Problems on Healthcare-Associated Infections In Japan
Kazuhiko Fukatsu (Japan)
SP 12-2
Strategies for New Problems on Healthcare-Associated Infections in Taiwan
Feng-Yee Chang (Taiwan)
SP 12-3
Strategies for New Problems on Healthcare-Associated Infections in China
Liuyi Li (China)
SP 12-4
The Role of the Patient in a Multidisciplinary Team - the Patient is “in"
Axel Kramer (Germany)
10:30-12:00, Saturday, March 28, 2015
Room 201 ABC (2F)
Symposium 13
Outbreak Investigation
Moderators: Yoshio Takesue (Japan); Bijie Hu (China)
SP 13-1
Spots and Dots: When Outbreak Investigation Meets "Reality"
Paul Anantharajah Tambyah (Singapore)
SP 13-2
When is an Outbreak Not an Outbreak?
Robert A. Weinstein (United States)
SP 13-3
Mycobacterium abscessus subspecies massiliense: An Emerging Healthcare Associated
Pathogen
Aristine Cheng (Taiwan)
SP 13-4
It Comes with Water
Anucha Apisarnthanarak (Thailand)
12
Updated on February 17, 2015
10:30-12:00, Saturday, March 28, 2015
Room 201 DEF (2F)
Symposium 14
Current Laboratory Methods for Epidemiological Investigation during Nosocomial Outbreak
Moderators: Yangsoon Lee (Korea); Wen-Shyang Hsieh (Taiwan)
SP 14-1
Laboratory Methods to Support Epidemiological Investigations during Outbreaks
Allen Cheng (Australia)
SP 14-2
MALDI-TOF-MS-based Species Identification and Typing Approaches in Mycobacterium
Hsin-Chih Lai (Taiwan)
SP 14-3
Whole-Genome Mapping: A New Paradigm in Strain-typing Technology
Yangsoon Lee (Korea)
10:30-12:00, Saturday, March 28, 2015
Room 103 (1F)
Symposium 15
Rapid Diagnosis for Infection Control
Moderators: Xiang-Sheng Chen (China); Leung Kei Siu (Taiwan)
SP 15-1
Molecular Diagnosis of Drug Resistance in Mycobacterium tuberculosis
Tsung Chain Chang (Taiwan)
SP 15-2
Rapid Diagnostics for Syphilis: an Overview of Test Performance and Introduction
Xiang-Sheng Chen (China)
SP 15-3
Rapid Detection of MDROs for Infection Control
Kyungwon Lee (Korea)
10:30-12:30, Saturday, March 28, 2015
Room 105 (1F)
Oral Session 10
Moderator: Ming Chin Chan (Taiwan); Yi-Hui Wu (Taiwan)
OS 10-1
Causes of Fatality Associated with Prospective Antimicrobial Audit with Feedback
Shu-Hsing Cheng (Taiwan)
OS 10-2
The Antimicrobial Stewardship Programmes Reduce Multidrug Resistant Acinetobacter
baumanii Infection in the Intensive Care Unit (ICU) of Siloam Hospital, Tangerang, Indonesia
Cucunawangsih (Indonesia)
OS 10-3
Evaluation of Levofloxacin Utilization Rationality by Computerized Physician Order Entry
System
Ya-Ling Ke (Taiwan)
OS 10-4
Evaluation of Piperacillin/tazbactam Utilization Appropriateness
Hsin-Chun Lai (Taiwan)
OS 10-5
Association Between Antimicrobial Treatment with Fluoroquinolones Versus Β-lactamase
Inhibitor and Risk of Pneumonia-related Hospitalization Among Patients with Chronic
Obstructive Pulmonary Disease
Kuan-Yin Lin (Taiwan)
OS 10-6
Improvement of Ciprofloxacin Utilization Rationality by Computerized Physician Order Entry
System
Hui-Hsia Hsieh (China)
OS 10-7
Decreased Antibiotic Resistance and Defined Daily Dose after Implementation of
13
Updated on February 17, 2015
Antimicrobial Stewardship Program in a Local Hospital in Taiwan
Hao-Yuan Lee (Taiwan)
OS 10-8
Application of Computer Network in Antibiotic Stewardship
Chenrong Mi (China)
OS 10-9
Antiobiotics Stewardship for Laparoscopic Cholecystectomy
Chih-Hao Hung (Taiwan)
13:40-14:20, Saturday, March 28, 2015
Plenary Hall (3F)
Keynote Speech 13
Moderator: Ching-Chuan Liu (Taiwan)
KS 13
Preventing Central Line-associated Bloodstream Infections in an Era of Zero Tolerance
William R. Jarvis (United States)
13:40-14:20, Saturday, March 28, 2015
Room 102 (1F)
Keynote Speech 14
Moderator: Chang-Phone Fung (Taiwan)
KS 14
National Approach to Reduce Healthcare-Associated Infections
Marilyn Cruickshank (Australia)
13:40-14:20, Saturday, March 28, 2015
Room 201 ABC (2F)
Keynote Speech 15
Moderator: Tzou-Yien Lin (Taiwan)
KS 15
Infection Control 2025
Andreas Voss (The Netherlands)
13:40-14:20, Saturday, March 28, 2015
Room 201 DEF (2F)
Keynote Speech 16
Moderator: Yung-Ching Liu (Taiwan)
KS 16
The Management and a New Strategy against CRE Infection
Kazuhiro Tateda (Japan)
15:00-16:30, Saturday, March 28, 2015
Plenary Hall (3F)
Symposium 16
Surgical Site Infections and the Operating Theatre
Moderators: Joseph Solomkin (United States); Lih-Shinn Wang (Taiwan)
SP 16-1
WHO and CDC Guidelines: Key Recommendations
Joseph Solomkin (United States)
SP 16-2
Surgical Unit-based Safety Program: Tapping into the Wisdom of Frontline Staff
Sean M. Berenholtz (United States)
SP 16-3
Small, Smaller, Smallest! How to (if ever) Clean and Sterilize Microsurgical Instruments and
Robot Arms?
Yu-Hui Chen (Taiwan)
SP 16-4
Surgical Checklists: Do They Improve Patient Safety?
14
Updated on February 17, 2015
Shu Lay Lee (Singapore)
15:00-16:30, Saturday, March 28, 2015
Room 102 (1F)
Symposium 17
Hospital Accreditation Program
Moderators: Visanu Thamlikitkul (Thailand); Ian M Gould (United Kingdom)
SP 17-1
WHONET – Tracking Microbes for Patient Safety
John Stelling (United States)
SP 17-2
Antibiotic Stewardship and Hospital Accreditation
Heiman Wertheim (Vietnam)
SP 17-3
Infection Control Accreditation Program
Andreas Voss (The Netherlands)
15:00-16:30, Saturday, March 28, 2015
Room 201 ABC (2F)
Symposium 18 (Co-organized by Taiwan Long Term Care Professional Association)
Infection and Infection Control in Long Term Care Facilities
Moderators: Minori Tokui (Japan); I-Chen Hung (Taiwan)
SP 18-1
Infection Control in Long Term Care Facility in Singapore
Shu Lay Lee (Singapore)
SP 18-2
Infection Control in Japanese Long Term Care Facility
Minori Tokui (Japan)
SP 18-3
Long Term Care Facilities System in Taiwan
Shyh-Dye Lee (Taiwan)
15:00-16:30, Saturday, March 28, 2015
Room 105 (1F)
Oral Session 11
Moderator: Wu Sun (Taiwan); TBD
OS 11-1
Advancement of Infection Control Practice Through Improving Hand Hygiene Compliance
Among Healthcare Workers at a Community Based Healthcare Setting
Lutfe Ara (Bangladesh)
OS 11-2
Increasing Occupational Safety of the Healthcare Workers of Bangladesh from Needle-stick
Injuries Through Education and Training
Lutfe Ara (Bangladesh)
OS 11-3
Study on Improvement of Hand Hygiene Compliance and Correctness of the Medical Staff in a
Large Hospital
Wei-Jia Yin (China)
OS 11-4
The Impact of Enhanced Strategy on the Effectiveness of Environmental Disinfection at High
Risk Areas
Moi Lin Ling (Singapore)
OS 11-5
Cleaning Verification: Is This Really Required?
Moi Lin Ling (Singapore)
OS 11-6
Dialysis and Oncology Unit Amalgamation – Should You Take the Risk?
Marilyn Butler (Australia)
15
Updated on February 17, 2015
OS 11-7
Prevention of Needlestick and Sharp Injuries Among Hospitals in Thailand
Akeau Unahalekhaka (Thailand)
OS 11-8
Conversion from a Traditional Bedpan Sanitizer to a Single-use Disposable System, to Eliminate
Bedpan Cleaning and Improve Operational Processes
Sharon Salmon (Singapore)
OS 11-9
Preventing Infections in Vascular Access – a Success Story
Geetha Samethadka (India)
15:00-16:30, Saturday, March 28, 2015
Room 201 DEF (2F)
Symposium 19
Fungal Infections and Environment
Moderators: TBD; Yee-Chun Chen (Taiwan)
SP 19-1
Think Fungus—Prevention and Control of Fungal Infections
Tom M. Chiller (United States)
SP 19-2
The Molecular Epidemiology of Human Fungal Pathogens
Shu-Ying Li (Taiwan)
SP 19-3
Insights into Cryptococcal meningitis in HIV-uninfected Chinese Patients
Liping Zhu (China)
15:00-16:30, Saturday, March 28, 2015
Room 103 (1F)
Symposium 20 (Co-Organized by Cargico Corp.)
Environmental Cleaning for MDRO Control
Moderators: Stephan Harbarth (Switzerland); Wen-Sen Lee (Taiwan)
SP 20-1
Control of Multi-Drug Resistant Gram-Positive Bacteria: Lessons from Recent Interventional
Studies in ICUs
Stephan Harbarth (Switzerland)
SP 20-2
Recent Development of Nanotechnology for Environmental Control of Colonization due to
Multidrug-resistant Bacteria in Healthcare Facilities
Muh-Yong Yen (Taiwan)
SP 20-3
Proactive Infection Control Measures to Prevent Nosocomial Transmission of VRE
Vincent Cheng (Hong Kong, SAR)
16
Updated on February 17, 2015
16:30-18:00, Saturday, March 28, 2015
Room 105 (1F)
Oral Session 12
Moderator: Mao-Wang Ho (Taiwan); Kuei-Chu Li (Taiwan)
OS 12-1
Preventing Infections Through Cleaner Hospitals (PITCH): an Environmental Cleaning Bundle
Michelle Allen (Australia)
OS 12-2
Evaluating the Efficacy of Environmental Cleanliness by Adenosine Triphosphate
Bioluminescence Assay at a Medical Center
Yu-Shan Huang (Taiwan)
OS 12-3
How Do Managers Work to Improve Hand Hygiene and Hygiene Procedures? - a Qualitative
Study at a Hospital in Stockholm
Monica Ling-Roos (Sweden)
OS 12-4
Does the Extensive Use of QAC Disinfectants Select for Enterotoxigenic Staphylococcus aureus?
Margaret O' Donoghue (Hong Kong, SAR)
OS 12-5
Characteristics and Potential Risks of Outbreaks in Postpartum Nursing Centers in Taiwan,
2007-2014
Hsin Yi Wei (Taiwan)
OS 12-6
Running an Infection Control Monthly Meeting Encouraged Communication Between the
Infection Control Team（ICT）and Clinical Units in a Hospital in China
Shilanxu Xu (China)
OS 12-7
Unexpected Low Hand Hygiene Compliance of Health Care Workers in Taiwan: a Nation-wide
Covert Observation Program
Kuan-Sheng Wu (Taiwan)
OS 12-8
Validity and Reliability of the Assessment for Hand Hygiene Observers
Wai Fong Chan (Hong Kong, SAR)
OS 12-9
Efficacy of Hydrogen Peroxide Vapour (HPV) for Environmental Disinfection of Operating Room
Yijung Liu (Taiwan)
17
Updated on February 17, 2015
Sunday, March 29, 2015
7:30-8:30, Sunday, March 29, 2015
Room 102 (1F)
Oral Session 13
Moderator: Hong Bin Kim (Korea); Guangxue He (China)
OS 13-1
Topical Vancomycin Powder Was Not Associated with Decreased Risk of Surgical Site Infections
(SSI) after Craniotomies or Craniectomies (CRANI)
Hsiu-Yin Chiang (United States)
OS 13-2
Daily Chlorhexidine Care at Exit Site in Patients with Peritoneal Dialysis: a Randomized Control
Trial
Jiun-Ling Wang (Taiwan)
OS 13-3
Establishing Prevention and Control Programme for Water-related Infections in a
Rehabilitation Hospital of Hong Kong
Wai Fong Chan (Hong Kong, SAR)
OS 13-4
Impact of Daily Bathing with Chlorhexidine Gluconate and Ventilator Associated Pneumonia in
Intensive Care Units: a Meta-analysis
Wensen Chen (China)
OS 13-5
Infection Control Intervention in Preventing Catheter Associated Bloodstream Infection at
Neonatal Department in Hung Vuong Hospital
Phan Thi Hang (Vietnam)
8:30-9:10, Sunday, March 29, 2015
Plenary Hall (3F)
Plenary Lecture 4
Moderators: Norio Sugaya (Japan)
PL 4
SARS, H7N9, and MERS: Can We Expect the Unexpected?
Wing Hong Seto (Hong Kong, SAR)
9:20-10:00, Sunday, March 29, 2015
Plenary Hall (3F)
Keynote Speech 17
Moderator: Kazuhiro Tateda (Japan)
KS 17
Controlling Multi-Drug Resistance
Ian M Gould (United Kingdom)
9:20-10:00, Sunday, March 29, 2015
Room 102 (1F)
Keynote Speech 18
Moderator: Cheng-Hua Huang (Taiwan)
KS 18
Hand Hygiene Promotion and the Participation of Infection Control Link Nurses: An Effective
Innovation to Overcome Campaign Fatigue
Patricia Ching (Hong Kong, SAR)
18
Updated on February 17, 2015
9:20-10:00, Sunday, March 29, 2015
Room 201 ABC (2F)
Keynote Speech 19
Moderator: Ursula Theuretzbacher (Austria)
KS 19
Infection Control in Multi-drug Resistant Organisms (MDROs)
Chun-Ming Lee (Taiwan)
9:20-10:00, Sunday, March 29, 2015
Room 201 DEF (2F)
Keynote Speech 20
Moderators: Jiunn-Jong Wu (Taiwan)
KS 20
WHONET – 25 (and 50) Year On
John Stelling (United States)
10:30-12:00, Sunday, March 29, 2015
Symposium 21
Plenary Hall (3F)
(Co-organized by International Society of Chemotherapy, ISC)
Antibiotic Stewardship
Moderators: Ian M Gould (United Kingdom); Yao-Shen Chen (Taiwan)
SP 21-1
Benefits of Antimicrobial Stewardship in Hospitals: Evidence from a Recent Cochrane Review
Ian M Gould (United Kingdom)
SP 21-2
Scaling up Evidence-based Interventions toward Sustainability: A Case Study of Antibiotics
Smart Use Program in Thailand
Nithima Sumpradit (Thailand)
SP 21-3
Hospital Initiatives
Ching-Tai Huang (Taiwan)
SP 21-4
An International Approach to Antimicrobial Stewardship: Example from Vietnam
Heiman Wertheim (Vietnam)
10:30-12:00, Sunday, March 29, 2015
Room 102 (1F)
Symposium 22
What's the Evidence for and Against Use of Chorhexidine for Prevention of Healthcare-associated Infections?
Moderators: William R. Jarvis (United States); Hsiu-Tzy Chiang (Taiwan)
SP 22-1
Dose CVC Care Bundle Work in Central Line Associated Blood Stream Infection (CLABSI)? - Take
Taiwan as an Example
Chun-Ming Lee (Taiwan)
SP 22-2
Use of Chlorhexidine to Prevent Surgical Site Infections
Keita Morikane (Japan)
SP 22-3
Prevention of Ventilator-associated Pneumonia
Glenys Harrington (Australia)
SP 22-4
Prevention of Catheter Associated Urinary Tract Infection (CAUTI) through Bundle of Care
Approach
Patricia Ching (Hong Kong, SAR)
19
Updated on February 17, 2015
10:30-12:00, Sunday, March 29, 2015
Room 201 ABC (2F)
Symposium 23
(Co-organized by Taiwan Society of Tuberculosis and Lung Diseases and ISC Working Group on Tuberculosis)
Reducing the Risk of Tuberculosis Transmission
Moderators: Edward A Nardell (United States); Wei-Juin Su (Taiwan)
SP 23-1
The Prevalence and Incidence of Latent Tuberculosis Infection and its Associated Factors
among Village Doctors in China
Guangxue He (China)
SP 23-2
Tuberculosis Contact Investigations among Healthcare Workers
Pei-Chun Chan (Taiwan)
SP 23-3
Principles of MDR-TB Control
Chen-Yuan Chiang (IUAT)
SP 23-4
Relevance of Latent TB Infection in Areas of High TB Prevalence
Cynthia Bin-Eng Chee (Singapore)
10:30-12:00, Sunday, March 29, 2015
Room 201 DEF (2F)
Symposium 24 (Co-organized by European Society of Clinical Microbiology and Infectious Diseases, ESCMID)
Control of MDRO in the Hospitals
Moderators:
SP 24-1
Giuseppe Cornaglia (Italy); Ping-Cherng Chiang (Taiwan)
Epidemiology: Asia vs. Europe
Giuseppe Cornaglia (Italy)
SP 24-2
Controlling VRE Using Technology
Dale Fisher (Singapore)
SP 24-3
Controlling the Healthcare-associated Spread of Carbapenem-resistant Enterobacteriaceae
David K. Henderson (United States)
SP 24-4
Stewardship Strategies to Control MDRO
Ursula Theuretzbacher (Austria)
20